AMBROSE HEALTHCARE (HOLDINGS) LTD

🌿Early-stageactive
15324624 · ltd · incorporated 2023-12-03
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
£100
book net assets
Opportunity
75/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and acceptable with review structure.

Opportunity 75/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (69/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
1 year of iXBRL accounts extracted (no YoY comparison) + narrative notes parsed
50
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (1 active, 2 linked, 2 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
6 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
75/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £100

Key financials

1 year extracted from filed iXBRL accounts
Cash
Net Worth
£100
Current Assets
Current Liabilities

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-03-31
Total assets£100
Net assets£100

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
0
filings
Counts from Companies House filing history.
Corporate timeline (8 events)Click to expand
  1. 2025-07-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2025-06-03
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  3. 2025-06-01
    WILSON WATERWORTH, Georgia Mary resigned
    director
  4. 2024-05-21
    📄
    change-account-reference-date-company-current-extended
    accounts · AA01
  5. 2023-12-03
    🏢
    Company incorporated
    As AMBROSE HEALTHCARE (HOLDINGS) LTD
  6. 2023-12-03
    WILSON WATERWORTH, Toby Adam appointed
    director
  7. 2023-12-03
    WILSON WATERWORTH, Georgia Mary appointed
    director
  8. 2023-12-03
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

88/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Senior director age: Director aged approximately 62 — approaching natural succession window.
  • +Young company: Only 2.6 years old — management layer unlikely to be developed.

Succession & seller-readiness

55/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • secondaryFounder aged 58+: Senior director is approximately 62. Early succession window.
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

Ambrose Healthcare Ltd is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️
Ambrose Healthcare Ltd
Corporate parent · holds 75-100% shares · board control
ultimate parent
AMBROSE HEALTHCARE (HOLDINGS) LTD
This company · 15324624

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Ambrose Healthcare Ltd
Corporate entity
75100%
75–100%board control75-100% shares · 75-100% voting · board control03/12/2023

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Professional services · CB postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ALPHUBEL LTD
12541436 · est 2020 · no financials extracted
6y
ALWAYS FIRE SAFETY LTD
13866022 · est 2022 · no financials extracted
4y
AMAREW LIMITED
12125934 · est 2019 · no financials extracted
6y
AMAVANTI LIMITED
10176461 · est 2016 · no financials extracted
9y
AMBERDEN ASSOCIATES LTD
13813377 · est 2021 · no financials extracted
4y
AMBROSE HEALTHCARE LTD
14409383 · est 2022 · no financials extracted
3y
AMG COMPOSITE TECHNOLOGIES LTD
11976184 · est 2019 · no financials extracted
6y
AMK BIOCONSULTING LTD
17091100 · est 2026 · no financials extracted
AMPASHIELD LIMITED
12577527 · est 2020 · no financials extracted
5y
AMPHISTA THERAPEUTICS LIMITED
11119959 · est 2017 · no financials extracted
8y
AMPKINE LIMITED
12065717 · est 2019 · no financials extracted
6y
AMPP SERVICES LIMITED
06445402 · est 2007 · no financials extracted
18y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2023-12-03
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

C/O Ashcroft, Stone Cross,
Trumpington Road,
Cambridge
CB2 9SU
United Kingdom

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2026-12-16
Last: 2025-12-02

Officers (1 active · 1 resigned)

WILSON WATERWORTH, Toby Adam
director · ~62y · appointed 2023-12-03
View their other companies + combined net worth →
Active
WILSON WATERWORTH, Georgia Mary
director · ~34y · appointed 2023-12-03 · resigned 2025-06-01
Resigned

Click a director name to see their full track record across all companies.

Recent filings (6 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-12-02
accounts-with-accounts-type-micro-entity
accounts · AA
2025-07-30
termination-director-company-with-name-termination-date
officers · TM01
2025-06-03
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-12-03
change-account-reference-date-company-current-extended
accounts · AA01
2024-05-21
incorporation-company
incorporation · NEWINC
2023-12-03